Profilo
Gunnar Pohl is the founder of Nordic Biomarker AB, which was founded in 2007.
He worked as a Director at MediRox AB from 2007 to 2009.
Precedenti posizioni note di Gunnar Pohl
| Società | Posizione | Fine |
|---|---|---|
| MEDIROX AB | Direttore/Membro del Consiglio | 29/04/2009 |
Nordic Biomarker AB
 Nordic Biomarker AB Pharmaceuticals: MajorHealth Technology Nordic Biomarker AB is a Swedish manufacturer of routine and specialty reagents for coagulation analysis. Nordic Biomarker is based in Umeå, SE. The Swedish company offers CE-marked kits and OEM products, available in vials or bulk, intended for calibration of MRX D-dimer assays run on coagulation analyzers, in ng/mL DDU. The company's FDP reagent is optimized for assay with coagulation analyzers at 500-700 nm, where 550 nm and 575 nm is most commonly used. The company was founded in 2007 by Gunnar Pohl and Göran Aronsson, and the CEO is Rikard Rodén. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
MediRox AB
 MediRox AB Pharmaceuticals: MajorHealth Technology MediRox AB engages in developing, manufacturing and marketing of control plasmas and diagnostic reagents for coagulation analytes. Its products include PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis. The company was founded in 1998 and is headquartered in Nykoping, Sweden. | Health Technology |
Nordic Biomarker AB
Nordic Biomarker AB Pharmaceuticals: MajorHealth Technology Nordic Biomarker AB is a Swedish manufacturer of routine and specialty reagents for coagulation analysis. Nordic Biomarker is based in Umeå, SE. The Swedish company offers CE-marked kits and OEM products, available in vials or bulk, intended for calibration of MRX D-dimer assays run on coagulation analyzers, in ng/mL DDU. The company's FDP reagent is optimized for assay with coagulation analyzers at 500-700 nm, where 550 nm and 575 nm is most commonly used. The company was founded in 2007 by Gunnar Pohl and Göran Aronsson, and the CEO is Rikard Rodén. | Health Technology |
- Borsa valori
- Insiders
- Gunnar Pohl
